European Commission clears Abbott acquisition of Alere

Alere, a global actor in rapid diagnostics, announced that the European Commission has granted clearance for Abbott Laboratories to acquire Alere.

This regulatory clearance marks a significant milestone toward the completion of our transaction with Abbott and we remain highly confident that the merger will close according to the terms of the agreement,” said Namal Nawana, CEO and President of Alere.

As previously announced on February 1, 2016, Alere has entered into a definitive agreement under which Abbott will acquire Alere for $56 per common share in cash.